ASLAN Pharmaceuticals Announces Late Breaking Abstract on Eblasakimab in COPD …

SAN MATEO, Calif. and SINGAPORE, April 24, 2024 (GLOBE NEWSWIRE) — ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused b.

Continue

Do you trust this headline?

Based on recent headline ratings, 100% of this readership currently trusts the local media, which has an average score of 85% regionally and is currently trending positivepositive.

100%

Media Trust Score100%

Read All

In

News